Literature DB >> 19328622

Photodynamic diagnosis using 5-aminolevulinic acid for the detection of positive surgical margins during radical prostatectomy in patients with carcinoma of the prostate: a multicentre, prospective, phase 2 trial of a diagnostic procedure.

Christoph Adam1, Georg Salomon, Sebastian Walther, Dirk Zaak, Wael Khoder, Armin Becker, Oliver Reich, Andreas Blana, Roman Ganzer, Stefan Denzinger, Gralf Popken, Ronald Sroka, Ruth Knüchel-Clarke, Jens Köllermann, Guido Sauter, Arndt Hartmann, Simone Bertz, Markus Graefen, Hartwig Huland, Wolf Wieland, Christian G Stief.   

Abstract

BACKGROUND: Surgical margin status after radical prostatectomy (RP) is a significant risk factor for tumour recurrence. It is an intriguing concept to find a fluorescence marker for photodynamic diagnosis (PDD) to make tumour margins visible during surgery.
OBJECTIVE: To investigate the feasibility of identification of positive surgical margins (PSM) during open retropubic or endoscopic extraperitoneal RP by 5-aminolevulinic acid (5-ALA)-induced protoporphyrin IX (PpIX) to enhance surgical radicality. DESIGN, SETTING, AND PARTICIPANTS: Thirty-nine patients (Gleason score 6-10, prostate-specific antigen [PSA] 2.3-120 ng/ml) received 20 mg/kg of body weight of 5-ALA orally and underwent RP (24 endoscopic extraperitoneal, 15 open retropubic). MEASUREMENTS: A PDD-suitable laparoscopy optic (Karl-Storz GmbH, Tuttlingen, Germany) with a yellow long-pass filter was coupled to a fibre-optic light cord with an excitation light source (380-420 nm, D-Light, Karl-Storz GmbH, Tuttlingen, Germany) for fluorescence excitation of PpIX and to a PDD-suitable camera for video and photo documentation by the AIDA DVD system (Karl-Storz GmbH, Tuttlingen, Germany). RESULTS AND LIMITATIONS: There were more false-negative cases in the open group (four vs two) than in the endoscopic group but more false-positive cases in the endoscopic group (two vs none) than in the open group. The overall sensitivity and specificity were 56% and 91.6%, respectively. The sensitivity of the endoscopic cases was much higher (75% vs 38%) than for the open cases, while the specificity was higher for the open group (88.2% vs 100%).
CONCLUSIONS: PDD with 5-ALA-induced PpIX during RP might be a feasible and effective method for reducing the rate of PSM. The technique seems to be more practicable during endoscopic RP rather than open RP. Further clinical studies with higher patient volumes and further development of the technique seem justified. TRIAL REGISTRATION: EudraCT: 2005-004406-93.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19328622     DOI: 10.1016/j.eururo.2009.02.027

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  10 in total

Review 1.  Oncologic Procedures Amenable to Fluorescence-guided Surgery.

Authors:  Kiranya E Tipirneni; Jason M Warram; Lindsay S Moore; Andrew C Prince; Esther de Boer; Aditi H Jani; Irene L Wapnir; Joseph C Liao; Michael Bouvet; Nicole K Behnke; Mary T Hawn; George A Poultsides; Alexander L Vahrmeijer; William R Carroll; Kurt R Zinn; Eben Rosenthal
Journal:  Ann Surg       Date:  2017-07       Impact factor: 12.969

Review 2.  Photodynamic diagnosis and therapy for urothelial carcinoma and prostate cancer: new imaging technology and therapy.

Authors:  Hideo Fukuhara; Shinkuro Yamamoto; Takashi Karashima; Keiji Inoue
Journal:  Int J Clin Oncol       Date:  2020-05-26       Impact factor: 3.402

3.  Hemodynamic effects of orally administered delta-ALA during radical prostatectomy.

Authors:  Volker Eichhorn; Alexander Maerz; Georg Salomon; Irmgard F Blanc; Daniel A Reuter; Alwin E Goetz
Journal:  World J Urol       Date:  2011-11-26       Impact factor: 4.226

4.  A ratiometric threshold for determining presence of cancer during fluorescence-guided surgery.

Authors:  Jason M Warram; Esther de Boer; Lindsay S Moore; Cecelia E Schmalbach; Kirk P Withrow; William R Carroll; Joshua S Richman; Anthony B Morlandt; Margaret Brandwein-Gensler; Eben L Rosenthal
Journal:  J Surg Oncol       Date:  2015-06-12       Impact factor: 3.454

Review 5.  5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence Imaging for Tumor Detection: Recent Advances and Challenges.

Authors:  Yoshinori Harada; Yasutoshi Murayama; Tetsuro Takamatsu; Eigo Otsuji; Hideo Tanaka
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

Review 6.  Intraoperative optical imaging and tissue interrogation during urologic surgery.

Authors:  Mark Hsu; Mohit Gupta; Li-Ming Su; Joseph C Liao
Journal:  Curr Opin Urol       Date:  2014-01       Impact factor: 2.309

7.  Efficacy of 5-aminolevulinic acid-mediated photodynamic therapy using light-emitting diodes in human colon cancer cells.

Authors:  Tomoya Hatakeyama; Yasutoshi Murayama; Shuhei Komatsu; Atsushi Shiozaki; Yoshiaki Kuriu; Hisashi Ikoma; Masayoshi Nakanishi; Daisuke Ichikawa; Hitoshi Fujiwara; Kazuma Okamoto; Toshiya Ochiai; Yukihito Kokuba; Katsushi Inoue; Motowo Nakajima; Eigo Otsuji
Journal:  Oncol Rep       Date:  2013-01-03       Impact factor: 3.906

Review 8.  Photodynamic therapy for prostate cancer: Recent advances, challenges and opportunities.

Authors:  Qin Xue; Jingliang Zhang; Jianhua Jiao; Weijun Qin; Xiaojian Yang
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

Review 9.  Fluorescence imaging in surgery.

Authors:  Ryan K Orosco; Roger Y Tsien; Quyen T Nguyen
Journal:  IEEE Rev Biomed Eng       Date:  2013-01-15

10.  Performance of 5-aminolevulinic-acid-based photodynamic diagnosis for radical prostatectomy.

Authors:  Hideo Fukuhara; Keiji Inoue; Atsushi Kurabayashi; Mutsuo Furihata; Taro Shuin
Journal:  BMC Urol       Date:  2015-08-01       Impact factor: 2.264

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.